Evidence map›Paper›PMID 34285249›Full record

ArticleScientific reports2021

Multi-omics integration of methyltransferase-like protein family reveals clinical outcomes and functional signatures in human cancer.

Ion John Campeanu, Yuanyuan Jiang, Lanxin Liu, Maksymilian Pilecki, Alvina Najor, Era Cobani, Morenci Manning, Xiaohong Mary Zhang, Zeng-Quan Yang

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Mettl1-dependent mNature communications · 2024
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ion John Campeanu *Department of Oncology, Wayne State University School of Medicine, Detroit, MI, USA.
Yuanyuan Jiang *Department of Oncology, Wayne State University School of Medicine, Detroit, MI, USA.
Lanxin LiuDepartment of Oncology, Wayne State University School of Medicine, Detroit, MI, USA.
Maksymilian PileckiDepartment of Oncology, Wayne State University School of Medicine, Detroit, MI, USA.
Alvina NajorDepartment of Oncology, Wayne State University School of Medicine, Detroit, MI, USA.
Era CobaniDepartment of Oncology, Wayne State University School of Medicine, Detroit, MI, USA.
Morenci ManningDepartment of Oncology, Wayne State University School of Medicine, Detroit, MI, USA.
Xiaohong Mary ZhangDepartment of Oncology, Wayne State University School of Medicine, Detroit, MI, USA.
Zeng-Quan YangDepartment of Oncology, Wayne State University School of Medicine, Detroit, MI, USA. yangz@karmanos.org.
Wayne State University · USThe Barbara Ann Karmanos Cancer Institute · US

Funding

Targeting USP10 to regulate the DNA damage response in NSCLCR21CA256423 · NCI · WAYNE STATE UNIVERSITY · PI BEPLER, GEROLD, ZHANG, XIAOHONG MARY · 2021 to 2022
$392k
NCI NIH HHS R21 CA256423
6 · The paper itself

Abstract

Human methyltransferase-like (METTL) proteins transfer methyl groups to nucleic acids, proteins, lipids, and other small molecules, subsequently playing important roles in various cellular processes. In this study, we performed integrated genomic, transcriptomic, proteomic, and clinicopathological analyses of 34 METTLs in a large cohort of primary tumor and cell line data. We identified a subset of METTL genes, notably METTL1, METTL7B, and NTMT1, with high frequencies of genomic amplification and/or up-regulation at both the mRNA and protein levels in a spectrum of human cancers. Higher METTL1 expression was associated with high-grade tumors and poor disease prognosis. Loss-of-function analysis in tumor cell lines indicated the biological importance of METTL1, an m

Indexed as

Carrier ProteinsCell Line, TumorCell ProliferationGene AmplificationGene Expression ProfilingGene Expression Regulation, NeoplasticGenomicsGTP-Binding ProteinsHumansMethyltransferasesModels, MolecularNeoplasm GradingNeoplasmsPrognosisProtein BindingProtein ConformationCarrier ProteinsGTP-Binding ProteinsMethyltransferasesMETTL1 protein, humanMETTL7B protein, humanNTMT1 protein, humanWDR4 protein, human

Identifiers

PMID34285249
PMCPMC8292347
OpenAlexW3185659293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.